Skip to main content

Table 4 Effect of influenza vaccination on respiratory, uro-genital, skin/bone/soft tissue and gastro-enteric infection risk

From: Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists

Site of infections

Influenza vaccination

Number of infections

Patient-years of follow-up

Rate

p

Respiratory

No

74

165.57

0.447

 
 

Yes

53

128.26

0.413

0.666

Uro-genital

No

58

117.92

0.492

 
 

Yes

53

113.65

0.466

0.781

Skin/Bone/Soft tissue

No

52

61.91

0.840

 
 

Yes

20

85.49

0.234

0.0001

Gastro-enteric

No

13

28.09

0.463

 
 

Yes

8

29.84

0.268

0.229